Miracor Medical Systems GmbH Receives Additional Funding To Accelerate Clinical Validation And Commercialization Of Its PICSO® Impulse System

VIENNA--(BUSINESS WIRE)--Miracor Medical Systems announced today that it has closed an extension to its Series B financing. The new investors BioMedInvest and aws Gründerfonds (“aws Founders Fund”) and the existing investors - Earlybird Venture Capital, Delta Partners and SHS – provided the additional investment of EUR 4.5 million for Miracor to expand clinical trials and commercialization with the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System.

Help employers find you! Check out all the jobs and post your resume.